EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,222,780 | +3.8% | 330,562 | -9.3% | 0.01% | +10.0% |
Q2 2023 | $6,961,620 | -11.0% | 364,292 | -9.6% | 0.01% | -16.7% |
Q1 2023 | $7,823,977 | +19.9% | 403,090 | -0.9% | 0.01% | +20.0% |
Q4 2022 | $6,527,061 | +3.6% | 406,924 | +1.3% | 0.01% | -9.1% |
Q3 2022 | $6,301,000 | -26.0% | 401,848 | -1.7% | 0.01% | -15.4% |
Q2 2022 | $8,514,000 | -6.7% | 408,942 | +1.6% | 0.01% | +8.3% |
Q1 2022 | $9,127,000 | +14.4% | 402,586 | -7.7% | 0.01% | +33.3% |
Q4 2021 | $7,977,000 | -28.2% | 436,379 | -17.0% | 0.01% | -35.7% |
Q3 2021 | $11,117,000 | +13.6% | 525,892 | -2.1% | 0.01% | +16.7% |
Q2 2021 | $9,785,000 | -19.8% | 537,050 | -0.6% | 0.01% | -25.0% |
Q1 2021 | $12,201,000 | +12.2% | 540,086 | -0.3% | 0.02% | +6.7% |
Q4 2020 | $10,877,000 | -15.5% | 541,965 | +3.0% | 0.02% | -28.6% |
Q3 2020 | $12,870,000 | +5.2% | 526,392 | +2.1% | 0.02% | -4.5% |
Q2 2020 | $12,236,000 | +41.8% | 515,403 | +2.8% | 0.02% | +15.8% |
Q1 2020 | $8,630,000 | +0.8% | 501,138 | +3.1% | 0.02% | +26.7% |
Q4 2019 | $8,561,000 | +1.3% | 485,869 | +1.7% | 0.02% | -6.2% |
Q3 2019 | $8,451,000 | -16.7% | 477,865 | +0.7% | 0.02% | -20.0% |
Q2 2019 | $10,146,000 | -8.2% | 474,774 | +2.3% | 0.02% | -13.0% |
Q1 2019 | $11,050,000 | +21.6% | 464,283 | +0.5% | 0.02% | +9.5% |
Q4 2018 | $9,086,000 | +13.6% | 461,926 | +2.3% | 0.02% | +31.2% |
Q3 2018 | $8,001,000 | -17.7% | 451,509 | -0.0% | 0.02% | -20.0% |
Q2 2018 | $9,720,000 | -2.0% | 451,662 | +0.8% | 0.02% | -4.8% |
Q1 2018 | $9,920,000 | -28.9% | 447,868 | -2.4% | 0.02% | -27.6% |
Q4 2017 | $13,954,000 | +23.7% | 459,011 | -1.4% | 0.03% | +16.0% |
Q3 2017 | $11,280,000 | -11.1% | 465,526 | -9.6% | 0.02% | -7.4% |
Q2 2017 | $12,686,000 | +30.6% | 515,076 | +14.9% | 0.03% | +35.0% |
Q1 2017 | $9,715,000 | +39.0% | 448,293 | -4.4% | 0.02% | +42.9% |
Q4 2016 | $6,991,000 | +13.5% | 468,893 | -2.7% | 0.01% | +7.7% |
Q3 2016 | $6,162,000 | +65.2% | 481,793 | +0.9% | 0.01% | +62.5% |
Q2 2016 | $3,729,000 | +95.2% | 477,493 | -0.0% | 0.01% | +100.0% |
Q1 2016 | $1,910,000 | -18.9% | 477,497 | +14.3% | 0.00% | -33.3% |
Q4 2015 | $2,356,000 | +2.2% | 417,800 | +1.6% | 0.01% | 0.0% |
Q3 2015 | $2,306,000 | +71.3% | 411,118 | +14.8% | 0.01% | +100.0% |
Q2 2015 | $1,346,000 | +47.4% | 358,018 | +0.7% | 0.00% | +50.0% |
Q1 2015 | $913,000 | +75.6% | 355,410 | -1.6% | 0.00% | +100.0% |
Q4 2014 | $520,000 | -5.5% | 361,010 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $550,000 | -54.4% | 359,474 | +1.1% | 0.00% | -66.7% |
Q2 2014 | $1,205,000 | -3.4% | 355,434 | +0.9% | 0.00% | 0.0% |
Q1 2014 | $1,247,000 | -38.8% | 352,334 | +5.9% | 0.00% | -50.0% |
Q4 2013 | $2,039,000 | +5.9% | 332,634 | +0.6% | 0.01% | 0.0% |
Q3 2013 | $1,925,000 | +32.4% | 330,734 | +3.3% | 0.01% | +20.0% |
Q2 2013 | $1,454,000 | -1.2% | 320,289 | +0.5% | 0.01% | 0.0% |
Q1 2013 | $1,472,000 | – | 318,691 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |